Detailed Information on Publication Record
2017
Structural Basis of the Interaction of Cyclin-Dependent Kinase 2 with Roscovitine and Its Analogues Having Bioisosteric Central Heterocycles
NEKARDOVÁ, Michaela, Ladislava VYMĚTALOVÁ, Prashant Kumar KHIRSARIYA, Silvia KOVÁČOVÁ, Michaela HYLSOVÁ et. al.Basic information
Original name
Structural Basis of the Interaction of Cyclin-Dependent Kinase 2 with Roscovitine and Its Analogues Having Bioisosteric Central Heterocycles
Authors
NEKARDOVÁ, Michaela (203 Czech Republic), Ladislava VYMĚTALOVÁ (203 Czech Republic), Prashant Kumar KHIRSARIYA (356 India, belonging to the institution), Silvia KOVÁČOVÁ (703 Slovakia, belonging to the institution), Michaela HYLSOVÁ (203 Czech Republic, belonging to the institution), Radek JORDA (203 Czech Republic), Vladimír KRYŠTOF (203 Czech Republic), Jindřich FANFRLÍK (203 Czech Republic), Pavel HOBZA (203 Czech Republic) and Kamil PARUCH (203 Czech Republic, guarantor, belonging to the institution)
Edition
ChemPhysChem, WEINHEIM, Wiley, 2017, 1439-4235
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10401 Organic chemistry
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.947
RIV identification code
RIV/00216224:14310/17:00097036
Organization unit
Faculty of Science
UT WoS
000402711100009
Keywords in English
computational chemistry; enzymes; protein– inhibitor interactions; purine bioisosteres; scaffold hopping
Tags
International impact, Reviewed
Změněno: 12/4/2018 00:19, Ing. Nicole Zrilić
Abstract
V originále
Although all the central scaffolds are very similar to the purine core of roscovitine, the experimentally determined IC50 values of the inhibitors span three orders of magnitude. By using an extensive computational chemistry approach, the affinities of the inhibitors to CDK2 are determined as calculated binding scores of complexes of the inhibitors with the protein. The interactions of the inhibitors with CDK2 are computationally described by using a hybrid quantum mechanics semi empirical quantum mechanics method QM SQM, which combines the DFT D method for the QM part and the PM6 D3H4X method for the SQM part. The solvent effect is described by the COSMO implicit solvation model at the SQM level for the whole system. The contributions of the scaffolds and the individual substituents, quantified and evaluated in relation to conformations of optimized protein inhibitor complexes, are found not to be simply additive. The inhibitory activity of the selected candidates, including two newly prepared compounds, is tested against CDK2. The results of the calculations are in close agreement with the experimental data.
Links
LM2015063, research and development project |
|